Delivery Order SPE2DB24D9245-SPE2DB25FHMHZ
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $2.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,016.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of IOSAT 130 mg tablets in quantities of 14. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price model with no set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,225.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of IOSAT 130 mg tablets in quantities of 14. The contract, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,466.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 27, 2024, is for the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product. This award is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $1,612.80 to DMS Pharmaceutical Group Inc. for IOSAT 130 mg tablets (14-count packaging) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a routine pharmaceutical supply transaction under DMS Pharmaceutical Group's existing...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $7,844.17 firm fixed-price delivery order for the supply of IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, with a performance period ending on December 6, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,996.50 firm fixed-price delivery order (SPE2DX25F6YXR) is for the provision of IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, with a period of performance through February 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,612.80 by the Defense Logistics Agency on August 12, 2025, for IOSAT 130 mg tablets (14-count package). This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, valued at approximately $500 million and...
- The Defense Logistics Agency awarded a delivery order valued at $7,844.17 to DMS Pharmaceutical Group Inc. on March 18, 2025, for the supply of IOSAT 130 mg tablets (14-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of March 19, 2025, and represents a small pharmaceutical supply requirement for federal healthcare operations. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,398.60 contract is for the delivery of IOSAT 130 MG TABLET 14S and has an August 22, 2023 completion date. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for IOSAT 130 mg tablets (14-count packaging). This firm fixed-price delivery order, valued at $1,612.80, was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. The order carries no set-aside designation and represents a purchase of potassium iodide tablets, which are used for thyroid...